Abstract:OBJECTIVE: Resistance to chemotherapy drugs makes ovarian cancer (OC) difficult to treat and ultimately kills patients. Long non-coding RNAs are closely related to carboplatin resistance in OC. In present study, we explored the role of lncRNA X-inactive specific transcript (XIST) on carboplatin resistance in OC.METHODS: Cell viability, proliferation, and apoptosis were assessed through 2,5-diphenyl-2H-tetrazolium bromide, colony formation, and flow cytometry assays, respectively. Microtubule-associated protein 1A/1B-light chain 3 expression was evaluated by immunofluorescence assay to analyze the cell autophagy. The interaction of XIST/miR-506-3p or miR-506-3p/forkhead box protein P1 (FOXP1) was analyzed using RNA immunoprecipitation (RIP) and dual-luciferases reporter assays. The function of XIST/miR-506-3p/FOXP1 axis in vivo was further confirmed by tumor xenograft study and immunohistochemistry.RESULTS: The expression of XIST and FOXP1 increased while miR-506-3p decreased in OC and carboplatin resistance cells. XIST silencing repressed the proliferative and autophagic capacities of carboplatin resistance cells while promoted the apoptosis. XIST overexpression led to the opposite results. XIST targeted miR-506-3p and downregulated its expression. MiR-506-3p inhibition facilitated the proliferative and autophagic capacities while suppressed the apoptosis of cells, XIST knockdown reversed these effects. MiR-506-3p bound to FOXP1. XIST knockdown or miR-506-3p overexpression reversed the increase of cell proliferative and autophagic abilities and the decrease of apoptosis rate induced by FOXP1 overexpression. XIST affected autophagy and carboplatin resistance in vivo via regulating the miR-506-3p/FOXP1 axis.CONCLUSION: XIST knockdown inhibited autophagy and carboplatin resistance of OC through FOXP1/protein kinase B (AKT)/mammalian target of rapamycin pathway by targeting miR-506-3p.

HOXC10 Promotes Carboplatin Resistance of Ovarian Cancer by Regulating ABCC3.

GANT61 Elevates Chemosensitivity to Cisplatin Through Regulating the Hedgehog, AMPK and Camp Pathways in Ovarian Cancer

Gene Expression Profile Analysis of the Molecular Mechanism of HOXD10 Regulation of Epithelial Ovarian Cancer Cells

HOXC10 Upregulation Confers Resistance to Chemoradiotherapy in ESCC Tumor Cells and Predicts Poor Prognosis

ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer

HOXB2 promotes cisplatin resistance by upregulating lncRNA DANCR in ovarian cancer

FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer

HOXD10 Acts As a Tumor-Suppressive Factor Via Inhibition of the RHOC/AKT/MAPK Pathway in Human Cholangiocellular Carcinoma

S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin

HOXC10 Promotes Tumour Metastasis by Regulating the EMT-related Gene Slug in Ovarian Cancer

Erratum: HOXC10 promotes carboplatin resistance of ovarian cancer by regulating ABCC3.

Hoxc10 Promotes Cell Migration, Invasion, And Tumor Growth In Gastric Carcinoma Cells Through Upregulating Proinflammatory Cytokines

The miR-33a-5p/CROT axis mediates ovarian cancer cell behaviors and chemoresistance via the regulation of the TGF-β signal pathway

Comprehensive Network Analysis of Dysregulated Genes Revealed MNX1-AS1/hsa-miR-4697-3p/HOXB13 Axis in Ovarian Cancer Chemotherapy Response.

Exploring the prognosis value, immune correlation, and drug responsiveness prediction of homeobox C6 (HOXC6) in lung adenocarcinoma

HOXA10 is Overexpressed in Human Ovarian Clear Cell Adenocarcinoma and Correlates with Poor Survival.

GATA1-induced Upregulation of LINC01503 Promotes Carboplatin Resistance in Ovarian Carcinoma by Upregulating PD-L1 Via Sponging Mir-766-5p

LncRNA XIST promotes carboplatin resistance of ovarian cancer through activating autophagy via targeting miR-506-3p/FOXP1 axis

Upregulation of HOXA10 Protein Expression Predicts Poor Prognosis for Colorectal Cancer.

Inferences of Carboplatin Response-Related Signature by Integrating Multiomics Data in Ovarian Serous Cystadenocarcinoma

HOXA1 silencing inhibits cisplatin resistance of oral squamous cell carcinoma cells via IκB/NF-κB signaling pathway